Obese children without comorbidities have impaired microvascular endothelial function
P Hedvall Kallerman1, E Hagman, A-K Edstedt Bonamy
1Divisions of Pediatrics, Department of Clinical Science, Intervention and Technology, Karolinska Institutet, Stockholm, Sweden.
Insights
Obese children show impaired endothelium-dependent vasodilatation, a key indicator of vascular health. Longer duration of obesity was linked to less severe impairment in microvascular endothelial function.
Area of Science:
- Pediatric Endocrinology
- Cardiovascular Physiology
- Vascular Biology
Background:
- Childhood obesity is a growing public health concern.
- Obesity is associated with endothelial dysfunction, a precursor to cardiovascular disease.
- Microvascular endothelial function in obese children without comorbidities requires further investigation.
Purpose of the Study:
- To assess acetylcholine-induced endothelium-dependent vasodilatation in obese children compared to normal-weight controls.
- To explore associations between endothelial function and risk factors like lipids, glucose metabolism, inflammation, blood pressure, fitness, and obesity duration.
Main Methods:
- Utilized transdermal iontophoresis of acetylcholine to induce endothelium-dependent vasodilatation.
- Measured changes in skin perfusion using laser Doppler flowmetry.
- Evaluated endothelial function in 54 obese children and 44 normal-weight controls, with subgroup analysis for risk factors.
Main Results:
- Obese children exhibited significantly lower acetylcholine-induced vasodilatation compared to controls (p < 0.001).
- Peak perfusion response was 33% lower in obese children (p = 0.001).
- A trend of lower vasodilatation was observed with higher triglyceride levels (p = 0.07), and shortest obesity duration showed lowest vasodilatation (p = 0.03).
Conclusions:
- Obese children, even without comorbidities, have demonstrably impaired microvascular endothelial function.
- Longer duration of obesity may be associated with a less pronounced impairment of endothelial function.
- Findings highlight the early impact of obesity on vascular health in children.
Aim:
The aim was to test acetylcholine-induced endothelium-dependent vasodilatation in obese children without comorbidities, compared with normal weight controls, and to analyse associations between vasodilatation and other potential risk factors.
Methods:
Endothelium-dependent vasodilatation was induced by transdermal iontophoresis of acetylcholine in 54 obese children (8.3-18.2 years old, 41% girls) and 44 normal weight controls (7.5-20.2 years old, 82% girls), and the subsequent change in perfusion was measured with laser Doppler flowmetry. In a subgroup of the obese children, associations between acetylcholine-induced vasodilatation and blood lipids, glucose/insulin metabolism, inflammation, 24-h ambulatory blood pressure (ABP), cardiovascular fitness and duration of obesity were evaluated.
Results:
We found a lower endothelium-dependent vasodilatory response to acetylcholine in the obese children than the controls (p < 0.001). The peak perfusion response was 33% lower in obese children (p = 0.001). There was a trend towards lower vasodilatation in obese children with higher levels of triglycerides (p = 0.07). Children with the shortest duration of obesity exhibited the lowest vasodilatation (p = 0.03). No associations were found between 24-h ABP, cardiovascular fitness, inflammation and glucose/insulin metabolism.
Conclusion:
Obese children without comorbidities have significantly impaired microvascular endothelial function. The children who had been obese for a longer time seemed less affected.
Related Concept Videos
Type I Diabetes II: Pathophysiology
Diabetic Retinopathy
Type II Diabetes II: Pathophysiology
Obesity
Pathophysiology of Diabetes
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution


